Analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a report released on Saturday. The firm set a "hold" rating on the stock.
Separately, Benchmark restated a "speculative buy" rating and issued a $1.25 target price on shares of Milestone Scientific in a research report on Wednesday, November 20th.
Get Our Latest Report on Milestone Scientific
Milestone Scientific Stock Up 2.0 %
NYSE MLSS traded up $0.02 on Friday, hitting $0.93. The stock had a trading volume of 34,370 shares, compared to its average volume of 135,573. Milestone Scientific has a one year low of $0.54 and a one year high of $1.39. The stock has a market cap of $72.28 million, a price-to-earnings ratio of -13.26 and a beta of 1.41. The company's 50-day moving average is $1.13 and its two-hundred day moving average is $0.96.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in MLSS. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific in the third quarter valued at approximately $48,000. World Investment Advisors LLC bought a new position in shares of Milestone Scientific in the third quarter valued at approximately $91,000. Renaissance Technologies LLC boosted its holdings in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after acquiring an additional 53,198 shares in the last quarter. Carnegie Investment Counsel boosted its holdings in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock worth $166,000 after buying an additional 27,412 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after buying an additional 31,572 shares in the last quarter. 5.79% of the stock is currently owned by institutional investors.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
